Adial Pharmaceuticals Inc (NASDAQ:ADIL)’s traded shares stood at 1.21 million during the last session, with the company’s beta value hitting 1.30. At the close of trading, the stock’s price was $2.32, to imply an increase of 3.57% or $0.08 in intraday trading. The ADIL share’s 52-week high remains $14.00, putting it -503.45% down since that peak but still an impressive 67.24% since price per share fell to its 52-week low of $0.76. The company has a valuation of $9.40M, with an average of 6.34 million shares over the past 3 months.

Adial Pharmaceuticals Inc (NASDAQ:ADIL) trade information

After registering a 3.57% upside in the last session, Adial Pharmaceuticals Inc (ADIL) has traded red over the past five days. The stock hit a weekly high of 3.10, jumping 3.57% in its intraday price action. The 5-day price performance for the stock is -0.43%, and 42.33% over 30 days. With these gigs, the year-to-date price performance is 24.73%.

Adial Pharmaceuticals Inc (ADIL) estimates and forecasts

Looking at statistics comparing Adial Pharmaceuticals Inc share performance against respective industry, we note that the company has outperformed competitors. Adial Pharmaceuticals Inc (ADIL) shares are -22.41% down over the last 6 months, with its year-to-date growth rate higher than industry average at 66.19% against 12.80%.

ADIL Dividends

Adial Pharmaceuticals Inc has its next earnings report out between May 10 and May 14. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Adial Pharmaceuticals Inc has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.